Bioequivalence of Two Fixed-dose Combination Tablets Containing Estradiol and Nomegestrol Acetate
Status:
Withdrawn
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
This study will investigate the bioavailability in fasting post-menopausal women of 2
film-coated tablet formulations containing 1.5 milligrams (mg) of estradiol and 2.5 mg of
nomegestrol acetate.
The study will be performed at a single site. Participants will take a single oral dose of
the test product and reference product in 2 periods and 2 sequences (either test after
reference or reference after test). There will be a washout of at least 21 days between each
study period.